Visit Flagship at the Spatial Biology for Drug Development Summit. October 11-13, 2023. Join us at the inaugural Spatial Biology for Drug Development Summit to explore implementation strategies, challenges in interpretation, and how this rapidly changing technology is...
Events
UPCOMING EVENTS
- American Society of Gene & Cell Therapy (ASGCT) Annual Meeting | May 7-11, Baltimore, MD (Booth #726)
- American Society of Clinical Oncology (ASCO) Annual Meeting | May 31 – June 4, Chicago, IL (Booth #37085)
- 3rd Annual Spatial Biology East Coast Congress | June 10-11, Boston, MA (Gold Sponsor)
- World CDx | September 4-6, Boston, MA (Spotlight Partner)
- Spatial Biology in Drug Development | October, Boston, MA (Program Partner)
13th Annual World Clinical Biomarkers & CDx Summit
Visit us at booth E30 to learn how we can partner for end-to-end support of your research and development program. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 13th Annual World Clinical Biomarkers & CDx...
June 2023 Annual Meeting
Flagship Bioscience is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance your precision medicine strategy. Attending the 2023...
American Society of Gene and Cell Therapy Annual Meeting
Visit us at booth 821 at the ASGCT Annual Meeting. We help you analyze more data in more depth, so you can produce more effective therapies. Attending the ASGCT Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions...
American Association for Cancer Research Annual Meeting
Visit Us at Booth 2866 in the West Building, Level 2 Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance...
Gene Therapy for Muscular Disorders
Reuniting 100+ leading experts in biotech, pharma, and academia. February 21-23, 2023. We’re headed to Boston to join other leading experts in biotech, pharma and academia to discuss obstacles in clinical trials and strategies for delivering safer and more effective...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
Recent Posts
NEWS
Flagship Biosciences hires Tom Turi, Ph.D. as CSO
Accomplished industry executive strengthens company’s position as a leader in spatial biology and biomarker analytics.BROOMFIELD, CO - September 27, 2022 — Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring...
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences
Acquisition significantly expands Flagship’s portfolio of biomarker and analytics servicesBroomfield, CO – August 31, 2022 — Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma...
A Digital Assay to Streamline PD-L1 IHC: Published in Scientific Reports
The journal Scientific Reports recently published a manuscript on the validation of Flagship’s new digital assay, Tissue Insight (TI) 22C3 NSCLC.1 This technology facilitates the otherwise cumbersome process of quantifying programmed cell death ligand 1 (PD-L1)...
PUBLICATIONS/POSTERS
Virtual Centralized Pathology = More Accurate Patient Data (Poster No. 10018 at Digital Pathology Association’s Pathology Visions 2021 #pathvisions21)
Background Historically, immunohistochemistry (IHC) assays have been designed for simplicity of manual pathology, however, this is not always ideal to acquire the appropriate data for patient selection and outcomes. Due to various challenges within the current...
Original Research Article (Pfizer): First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7 (PTK7), in Advanced Solid Tumors
In the downloadable original research article sponsored by Pfizer, the digital tissue analysis was performed using the Flagship Biosciences proprietary Image Analysis platform. The article was published in the Journal: Clinical Cancer Research online first on June 3,...
Original Research Article: Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
In partnership with Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, Flagship Biosciences published this downloadable original research article. It was first published on Monday, May 10...